期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Nature Reviews Urology LetPub Score 8.5
51 ratings
Rate
Reputation 9.8 Influence 7.8 Speed 6.9 | ||||||||||||||||
期刊簡稱 | NAT REV UROL | ||||||||||||||||
ISSN | 1759-4812 | ||||||||||||||||
E-ISSN | 1759-4820 | ||||||||||||||||
h-index | 65 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 1.70%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.nature.com/nrurol | ||||||||||||||||
在線稿件提交 | https://mts-nrurol.nature.com/ | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 2009 | ||||||||||||||||
每年文章數 | 49每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 4.41% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-4812%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Nature Reviews Urology] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:59:54 評論於 The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Depending on the article and the author, the length of the discussion section can vary, ranging from a few thousand words to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:02:28 評論於 The discussion section is the core part of a SCI paper, as it can reflect the breadth and depth of the author's research. Therefore, there is no limit to the number of words in this section. Different articles and authors will have different word counts in the discussion section, ranging from a few thousand to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:49:09 評論於 How many words should be limited in a discussion?(0) 讚! | 龙鳞孝礼 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 09:24:50 評論於 Does the lengthy discussion show the author's thoughtful consideration of the topic? Does it impress the reviewers positively?(0) 讚! | 龙鳞孝礼 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 13:59:42 評論於 We made a fortune! Published an article last year, now it's over 6 points. Dear friends, you also need to have such vision(0) 讚! | 凌霄高洁 |
作者: Les Wycliffe 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-11 13:36:45 評論於 The submission link is not visible(0) 讚! | Les Wycliffe |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 11:17:37 評論於 Look bullish, if it rises a bit more tomorrow, there's a chance to break 3 points(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us